61 – 70 of 76
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2006
- 
                        Mark
        Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation
    
    - Contribution to journal › Article
 
- 
                        Mark
        MLL/GAS7 fusion in a pediatric case of t(11;17)(q23;p13)-positive precursor B-cell acute lymphoblastic leukemia
    
    - Contribution to journal › Letter
 
- 
                        Mark
        The involvement of cellular proliferation status in the expression of the human proto-oncogene DEK
    
    - Contribution to journal › Letter
 
- 
                        Mark
        Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes
    
    - Contribution to journal › Article
 
- 2005
- 
                        Mark
        The Malmö International Brother Study (MIBS). Genetic defects and inhibitor development in siblings with severe hemophilia A.
    
    - Contribution to journal › Article
 
- 
                        Mark
        Resolving T-cell receptor clonality in two and genotype in four multiplex polymerase chain reactions.
    
    - Contribution to journal › Article
 
- 
                        Mark
        Biosynthetic profiles of neutrophil serine proteases in a human bone marrow-derived cellular myeloid differentiation model
    
    - Contribution to journal › Article
 
- 2004
- 
                        Mark
        Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma
    
    - Contribution to journal › Article
 
- 
                        Mark
        Low serum level of soluble tumor necrosis factor receptor p55 predicts response to thalidomide in advanced multiple myeloma
    
    - Contribution to journal › Article
 
- 
                        Mark
        Additional transplantation of ex vivo generated megakaryocytic cells after high-dose chemotherapy
    
    - Contribution to journal › Letter
 
